The only significant predictors for DFS in our analyses were tumor stage, nodal stage, hormone-receptor status, and HER2 status, while the final model for DDFS included age, tumor stage, nodal stage, hormone-receptor status, and menopausal status (Table 2). The gene discussed is NR4A1; the disease is neoplasm.